跳至主要内容
临床试验/NCT00647556
NCT00647556已完成3 期

A Comparative Study of Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream, for the Treatment of Photodamage

Galderma R&D1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Galderma R&D
入组人数
30
试验地点
1
主要终点
Change From Baseline in Overall Integrated Assessment of Photodamage at Week 24

研究概览

简要总结

The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessment as a secondary objective.

详细描述

Same as above.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or Female aged 40 years of age and older with Fitzpatrick skin types I through III
  • Clinically moderate to severe photodamage

排除标准

  • Subjects with history of laser resurfacing, dermabrasion, medium or deep chemical peel of the face
  • Subjects with diagnosis of skin cancer within 3 months of study entry
  • Subjects who have had superficial chemical peels, exfoliation or microdermabrasion of the face within 3 months of study entry
  • Subjects who have had botulinum toxin for facial rejuvenation within 6 months of study entry and are unwilling to refrain from botulinum toxin treatments during the study

研究组 & 干预措施

adapalene

Active Comparator

adapalene

干预措施: adapalene gel, 0.3% (Drug)

tretinoin

Active Comparator

Tretinoin

干预措施: tretinoin 0.05% emollient cream (Drug)

结局指标

主要结局

Change From Baseline in Overall Integrated Assessment of Photodamage at Week 24

时间窗: baseline to week 24

Number of participants who improved (a decrease by at least one point) in Overall Integrated Assessment of Photodamage from baseline to week 24. Overall Integrated Assessment of Photodamage is a scale from 0 - 5 (0 = None, 1 = Minimal, 2 = Mild, 3 - Moderate, 4 = Severe and 5 = Very Severe) with 0 being best and 5 being worst.

次要结局

  • Number of Participants in Each Category of the Subject Evaluation of Improvement at Week 12 and Week 24(week 12 and week 24)
  • Number of Participants in Each Category of the Investigator Evaluation of Global Response (Improvement) at Week 12 and Week 24(week 12 and week 24)
  • Number of Participants Who Improved (a Decrease of at Least One Point) in Overall Integrated Assessment of Photodamage From Baseline to Week 12.(baseline to week 12)
  • Photonumeric Scale for the Assessment of Photodamage From Baseline to Week 12 and Baseline to Week 24(baseline, week 12 and week 24)

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient... | 临床试验